ETFIQ
RankingsCompareHoldingsResearch
My portfolioWeekly note

JDOC · JPMorgan Healthcare Leaders ETF

Equity fundActively managed0.65% fee$9mSince Nov 2, 2023SEC filings ↗
Share on XDownload as PDFCompareAdd to portfolioAlerts

JDOC is actively managed and returned +11.6% over the past year.

+11.6%
Total return, 1 year
0.65%
Expense ratio
56
Holdings
−7.9%
Below its high
WindowTotal returnS&P 500Gap to S&P 500Gap to Nasdaq-100
3M Jul 2 – Oct 2, 2026−3.8%+3.6%−7.3 pts−9.1 pts
6M Apr 2 – Oct 2, 2026+7.2%+17.9%−10.7 pts−21.2 pts
1Y Oct 2, 2025 – Oct 2, 2026+11.6%+16.2%−4.6 pts−12.7 pts
Since listing Nov 2, 2023 – Oct 2, 2026+30.2%+85.3%−55.1 pts−79.6 pts

JDOC over each window to Oct 2, 2026. Every figure is an ETFIQ calculation. Source: ETFIQ.

JDOC top ten by weight, 48.5% of its 56 equity positions, from the holdings filed for Jul 31, 2026. An index fund holds what the index holds, so this is the index. Source: the fund’s SEC filing.

AbbVie, Inc. 7.91%
Eli Lilly & Co. 7.82%
UnitedHealth Group, Inc. 5.90%
Merck & Co., Inc. 4.86%
Johnson & Johnson 4.86%
AstraZeneca plc 3.79%
Thermo Fisher Scientific, Inc. 3.76%
Bristol-Myers Squibb Co. 3.60%
Abbott Laboratories 3.13%
CVS Health Corp. 2.85%
Fund filings on SEC EDGAR ↗
Head to head
Funds near this one
ACWIACWXAIRRAORAVDVAVEM

In plain words

JDOC is actively managed and tracks no index. Over the year to Oct 2, 2026 it returned +11.6% with distributions reinvested, against +16.2% for the S&P 500 and +24.3% for the Nasdaq-100. The prospectus expense ratio is 0.65% a year. By its holdings filed for Jul 31, 2026, 67% of the fund by weight is stocks the S&P 500 also holds, across 56 positions, with the top ten at 48.5%. It sat 7.9% below its high of Aug 25, 2026 on Oct 2, 2026.
What it tracksNo index, actively managed
Fund typeEquity fund
Category (ETFIQ)Stocks · Health care
Expense ratio (485BPOS XBRL, Feb 25, 2026)0.65%
Price$59.56
Listed sinceNov 2, 2023
Net assets (issuer page, as of Oct 2, 2026)$9m
Below its high (ETFIQ)−7.9%
Holdings56
Top ten weight48.5%
Holdings as of (SEC N-PORT)Jul 31, 2026
Already in the S&P 500, by weight (ETFIQ)67.3%
Active share vs the S&P 500 (ETFIQ)93.3%
Already in the Nasdaq-100, by weight (ETFIQ)6.1%
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

Questions people ask about JDOC

How has JDOC performed?
Over the year to Oct 2, 2026, JDOC returned +11.6% with distributions reinvested, against +16.2% for the S&P 500. Over three years the figure is not published.
What does JDOC cost?
The prospectus expense ratio is 0.65% a year.
What does JDOC hold?
56 positions as filed for Jul 31, 2026, with the top ten at 48.5% of the fund. 67% of its weight is in stocks the S&P 500 also holds.
How far is JDOC below its high?
7.9% below its high of Aug 25, 2026, measured on the reinvested series to Oct 2, 2026.
Sources and dates
Prices, JDOC and S&P 500Tiingo end-of-day · Oct 2, 2026
Fee, 0.65%Prospectus filing with the expense ratio (SEC) ↗
Net assets, $9mIssuer page · Oct 2, 2026
HoldingsHoldings filing (SEC Form N-PORT) · Jul 31, 2026 ↗
IssuerJPMorgan website ↗
All fund filingsFund filings on SEC EDGAR ↗
SourceJPMorgan’s own site ↗

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

ETFIQ covers core, leveraged and inverse, buffer, thematic, option-income, alternatives and spot crypto ETFs. This fund is here because the other funds here are measured against it and portfolios hold it. ETFIQ is an independent publisher and makes no recommendations. Standards and sources

How these figures are computed →Standards and sources →Open data →
Cite this page

ETFIQ, JDOC, core fund, data as of Oct 2, 2026. https://etfiq.com/funds/jdoc

Free to use with attribution; the underlying files are at Open data.

JPMorgan: every fund ETFIQ covers→